France· FR:66216027
AFSTYLA 250 UI, poudre et solvant pour solution injectable
A lonoctocog alfa product, registered in France by CSL BEHRING (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- CSL BEHRING (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- B02BD35
- ATC class
- Lonoctocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550290381 flacon en verre de 250 UI + 1 flacon en verre de 2,5 ml (100 UI/ml) + 1 dispositif de transfert avec filtre + 1 seringue + 1 kit de ponction veineuse + 2 tampons + 1 pansement
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lonoctocog alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAfstyla 250 IE poeder en oplosmiddel voor oplossing voor injectieCSL Behring GmbH
- SwedenAFSTYLA 1000 IE Pulver och vätska till injektionsvätska, lösningCSL Behring GmbH
- NorwayAfstylaCSL Behring GmbH (2)
- PolandAfstylaCSL Behring GmbH
- BelgiumAfstyla 1000 IUCSL Behring
- CzechiaAFSTYLACSL Behring GmbH, Marburg
- SpainAFSTYLA 1.000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLECsl Behring Gmbh
- FinlandAfstylaCSL Behring GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Afstyla
- Liechtenstein · Afstyla
- Norway · Afstyla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1cf7663-c32c-4f02-b752-23f5e977d6f5 GET /v1/drugs/e1cf7663-c32c-4f02-b752-23f5e977d6f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66216027",
"date_amm": "2017-01-04",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1158",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about lonoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.